A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

Summary

This trial was conducted in Europe. The aim of this clinical trial was to compare the exposure and effect of NN1250 (insulin degludec) after different routes of injection in healthy subjects.

Timeline

Start

2010-06

Primary completion

2010-10

Completion

2010-10

Publications

• Results Nosek L, Coester HV, Roepstorff C, Thomsen HF, Kristensen NR, Haahr H, Heise T. Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region. Clin Drug Investig. 2014 Sep;34(9):673-9. doi: 10.1007/s40261-014-0218-x.

Drugs

Indications